Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease
- 31 March 1995
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 25 (3), 445-451
- https://doi.org/10.1016/0272-6386(95)90107-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPDKidney International, 1994
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- Serum Advanced Glycosylation End Products: A New Class of Uremic Toxins?Blood Purification, 1994
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.Journal of Clinical Investigation, 1993
- Effects of kidney or kidney-pancreas transplantation on plasma pentosidineKidney International, 1993
- End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen.Journal of Clinical Investigation, 1990
- Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor αKidney International, 1990
- Isolation, Purification and Partial Characterization of Novel Fluorophores from aging Human Insoluble Collagen-Rich TissueConnective Tissue Research, 1989
- Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue RemodelingScience, 1988
- Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysisKidney International, 1984